Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents
Executive Summary
The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market
You may also be interested in...
Medicaid Reform Next On Health Care Agenda: GAO To Assess Rebates
The House Energy & Commerce/Oversight Subcommittee is directing the General Accounting Office to review Medicaid reimbursement policies in preparation for debate over reforms to the program
Medicaid Reform Next On Health Care Agenda: GAO To Assess Rebates
The House Energy & Commerce/Oversight Subcommittee is directing the General Accounting Office to review Medicaid reimbursement policies in preparation for debate over reforms to the program
Chain Drug Medicaid Pricing Records Sought By House Committee
Drug store chains have until Feb. 13 to submit to congressional investigators records of drugs purchased based on the "spread" between the pharmacies' actual acquisition costs and Medicaid's reimbursement rates for the products